Beijing Tiantan Biological Products Corp Ltd banner

Beijing Tiantan Biological Products Corp Ltd
SSE:600161

Watchlist Manager
Beijing Tiantan Biological Products Corp Ltd Logo
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Watchlist
Price: 15.95 CNY -2.63% Market Closed
Market Cap: ¥31.5B

Wall Street
Price Targets

Price Targets Summary
Beijing Tiantan Biological Products Corp Ltd

Wall Street analysts forecast Beijing Tiantan Biological Products Corp Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beijing Tiantan Biological Products Corp Ltd is 24.62 CNY with a low forecast of 22.83 CNY and a high forecast of 27.11 CNY.

Lowest
Price Target
22.83 CNY
43% Upside
Average
Price Target
24.62 CNY
54% Upside
Highest
Price Target
27.11 CNY
70% Upside
Beijing Tiantan Biological Products Corp Ltd Competitors:
Price Targets
CDNA
CareDx Inc
34% Upside
HCAT
Health Catalyst Inc
138% Upside

Revenue
Forecast

12% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Beijing Tiantan Biological Products Corp Ltd's revenue is 12%. The projected CAGR for the next 3 years is 10%.

Operating Income
Forecast

15% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
13%
Average Beat
15% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
13%
Average Beat

For the last 13 years the compound annual growth rate for Beijing Tiantan Biological Products Corp Ltd's operating income is 15%. The projected CAGR for the next 3 years is 3%.

Net Income
Forecast

16% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
16% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 13 years the compound annual growth rate for Beijing Tiantan Biological Products Corp Ltd's net income is 16%. The projected CAGR for the next 3 years is 3%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beijing Tiantan Biological Products Corp Ltd's stock price target?
Price Target
24.62 CNY

According to Wall Street analysts, the average 1-year price target for Beijing Tiantan Biological Products Corp Ltd is 24.62 CNY with a low forecast of 22.83 CNY and a high forecast of 27.11 CNY.

What is Beijing Tiantan Biological Products Corp Ltd's Revenue forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Beijing Tiantan Biological Products Corp Ltd's revenue is 12%. The projected CAGR for the next 3 years is 10%.

What is Beijing Tiantan Biological Products Corp Ltd's Operating Income forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Beijing Tiantan Biological Products Corp Ltd's operating income is 15%. The projected CAGR for the next 3 years is 3%.

What is Beijing Tiantan Biological Products Corp Ltd's Net Income forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Beijing Tiantan Biological Products Corp Ltd's net income is 16%. The projected CAGR for the next 3 years is 3%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett